Crinetics Pharmaceuticals, Inc. (CRNX) NASDAQ

30.32

-0.4(-1.30%)

Updated at August 18 02:41PM

Currency In USD

Valuation

Market Cap4.13B
Enterprise Value3.92B
P/E Ratio-7.71
PEG Ratio1.02
Price/Sales Ratio2,056.71
Price/Book Ratio2.43
Enterprise/Revenue2,053.99
Enterprise/EBITDA-6.8

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-265.69
Operating Margin-303.92

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.32

Income Statement

Revenue1.04M
Revenue/Share0.01
Gross Profit1.04M
EBITDA-338.85M
Net Income-298.41M
Diluted EPS-3.69

Balance Sheet

Total Cash1.2B
Total Cash/Share12.76
Total Debt49.94M
Total Debt/Equity0.04
Current Ratio17.8
Book Value Per Share12.49

Price History

52-Week Change-42.55
52-Week High62.53
52-Week Low24.1
Moving Average 50 Days30.38
Moving Average 200 Days38.37

Statistics

Average Volume829,320
Shares Outstanding94.18M
% Held by Institutions111.46

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A